Philadelphia 76ers · — · #—
—
| Period | GP | MIN | PTS | REB | AST | PRA | STL | BLK | TOV | 2PM | 2PA | 2P% | 3PM | 3PA | 3P% | FTM | FTA | FT% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Last 3 | 3 | 17.3 | 7.7 | 1.3 | 1.0 | 10.0 | 1.3 | 0.0 | 0.7 | 1.3 | 4.0 |
| 33.3% |
| 1.7 |
| 3.3 |
| 50.0% |
| 0.0 |
| 0.0 |
| 0.0% |
| Last 5 | 5 | 13.4 | 5.0 | 0.8 | 0.6 | 6.4 | 1.2 | 0.0 | 0.4 | 1.0 | 2.8 | 35.7% | 1.0 | 2.4 | 41.7% | 0.0 | 0.0 | 0.0% |
| Last 10 | 10 | 12.4 | 5.2 | 0.6 | 0.7 | 6.5 | 0.7 | 0.0 | 0.5 | 1.1 | 2.3 | 47.8% | 0.9 | 2.3 | 39.1% | 0.3 | 0.4 | 75.0% |
| Last 20 | 20 | 18.4 | 9.2 | 1.6 | 1.8 | 12.5 | 1.2 | 0.1 | 0.6 | 2.1 | 3.7 | 56.0% | 1.4 | 3.4 | 43.3% | 0.6 | 0.8 | 75.0% |
| Season | 64 | 15.3 | 6.0 | 1.5 | 1.2 | 8.8 | 0.8 | 0.2 | 0.6 | 1.2 | 2.2 | 54.3% | 1.0 | 2.8 | 37.2% | 0.5 | 0.6 | 84.6% |
high off-ball shooting, low offensive rebounding, low assist rate, low rim finishing off the ball
2025-26 season · fitted over 2022-23–2025-26
Style profile over 446 qualified players (8+ games, 10+ min/game). 100% is an identical profile; 50% is unrelated.
| Date | Matchup | W/L | MIN | PTS | REB | AST | STL | BLK | TOV | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-12 | PHI vs. MIL | W | 22.5 | 17 | 1 | 2 | 4 | 0 | 1 | 6 | 13 | 46.2% | 5 | 8 | 62.5% | 0 | 0 | 0.0% | 24.0 |
| 2026-04-10 | PHI @ IND | W | 16.2 | 2 | 1 | 1 | 0 | 0 | 1 | 1 | 4 | 25.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 2.0 |
| 2026-04-09 | PHI @ HOU | L | 13.2 | 4 | 2 | 0 | 0 | 0 | 0 | 2 | 5 | 40.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 12.0 |
| 2026-04-06 | PHI @ SAS | L | 5.5 | 2 | 0 | 0 | 1 | 0 | 0 | 1 | 2 | 50.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -5.0 |
| 2026-04-04 | PHI vs. DET | L | 9.8 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -13.0 |
| 2026-04-01 | PHI @ WAS | W | 9.3 | 5 | 1 | 1 | 0 | 0 | 0 | 1 | 4 | 25.0% | 1 | 3 | 33.3% | 2 | 2 | 100.0% | -9.0 |
| 2026-03-30 | PHI @ MIA | L | 0.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 3.0 |
| 2026-03-28 | PHI @ CHA | W | 8.0 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 50.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 13.0 |
| 2026-03-25 | PHI vs. CHI | W | 14.5 | 12 | 0 | 1 | 0 | 0 | 0 | 5 | 7 | 71.4% | 1 | 3 | 33.3% | 1 | 2 | 50.0% | 20.0 |
| 2026-03-23 | PHI vs. OKC | L | 24.8 | 8 | 1 | 2 | 1 | 0 | 3 | 3 | 7 | 42.9% | 2 | 4 | 50.0% | 0 | 0 | 0.0% | -18.0 |
| 2026-03-21 | PHI @ UTA | W | 25.3 | 8 | 0 | 1 | 1 | 0 | 0 | 3 | 10 | 30.0% | 1 | 5 | 20.0% | 1 | 1 | 100.0% | 5.0 |
| 2026-03-19 | PHI @ SAC | W | 33.3 | 32 | 0 | 4 | 2 | 0 | 0 | 11 | 18 | 61.1% | 7 | 11 | 63.6% | 3 | 3 | 100.0% | 47.0 |
| 2026-03-17 | PHI @ DEN | L | 24.8 | 11 | 5 | 3 | 1 | 1 | 1 | 4 | 12 | 33.3% | 2 | 7 | 28.6% | 1 | 1 | 100.0% | -16.0 |
| 2026-03-15 | PHI vs. POR | W | 25.0 | 21 | 2 | 2 | 2 | 0 | 2 | 9 | 14 | 64.3% | 3 | 5 | 60.0% | 0 | 0 | 0.0% | 4.0 |
| 2026-03-14 | PHI vs. BKN | W | 30.9 | 19 | 4 | 2 | 3 | 2 | 1 | 9 | 13 | 69.2% | 0 | 3 | 0.0% | 1 | 2 | 50.0% | 6.0 |
| 2026-03-12 | PHI @ DET | L | 29.3 | 12 | 9 | 5 | 4 | 0 | 1 | 5 | 11 | 45.5% | 0 | 2 | 0.0% | 2 | 4 | 50.0% | -5.0 |
| 2026-03-10 | PHI vs. MEM | W | 6.1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 6.0 |
| 2026-03-09 | PHI @ CLE | L | 28.2 | 14 | 2 | 3 | 2 | 0 | 1 | 5 | 6 | 83.3% | 3 | 4 | 75.0% | 1 | 1 | 100.0% | -2.0 |
| 2026-03-04 | PHI vs. UTA | W | 15.2 | 5 | 2 | 4 | 2 | 0 | 0 | 2 | 5 | 40.0% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 6.0 |
| 2026-03-03 | PHI vs. SAS | L | 26.5 | 9 | 1 | 3 | 0 | 0 | 1 | 3 | 7 | 42.9% | 3 | 5 | 60.0% | 0 | 0 | 0.0% | -18.0 |
| 2026-02-24 | PHI @ IND | W | 6.8 | 2 | 0 | 1 | 1 | 0 | 0 | 1 | 2 | 50.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -5.0 |
| 2026-02-22 | PHI @ MIN | W | 3.0 | 5 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 66.7% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 6.0 |
| 2026-02-21 | PHI @ NOP | L | 6.1 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -7.0 |
| 2026-02-11 | PHI vs. NYK | L | 22.3 | 4 | 3 | 1 | 1 | 0 | 0 | 2 | 7 | 28.6% | 0 | 3 | 0.0% | 0 | 0 | 0.0% | -26.0 |
| 2026-02-09 | PHI @ POR | L | 24.5 | 12 | 4 | 2 | 3 | 0 | 1 | 3 | 5 | 60.0% | 2 | 2 | 100.0% | 4 | 4 | 100.0% | 0.0 |
| 2026-02-07 | PHI @ PHX | W | 16.5 | 2 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 16.0 |
| 2026-02-05 | PHI @ LAL | L | 5.0 | 2 | 1 | 0 | 0 | 0 | 0 | 1 | 2 | 50.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 0.0 |
| 2026-02-03 | PHI @ GSW | W | 2.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -3.0 |
| 2026-01-29 | PHI vs. SAC | W | 7.1 | 3 | 1 | 0 | 0 | 0 | 0 | 1 | 2 | 50.0% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | -4.0 |
| 2026-01-27 | PHI vs. MIL | W | 24.3 | 8 | 3 | 1 | 1 | 0 | 1 | 3 | 5 | 60.0% | 2 | 4 | 50.0% | 0 | 0 | 0.0% | 14.0 |
| 2026-01-26 | PHI @ CHA | L | 16.4 | 4 | 1 | 2 | 1 | 0 | 0 | 1 | 3 | 33.3% | 0 | 2 | 0.0% | 2 | 2 | 100.0% | 1.0 |
| 2026-01-20 | PHI vs. PHX | L | 12.0 | 5 | 1 | 2 | 0 | 1 | 0 | 2 | 2 | 100.0% | 1 | 1 | 100.0% | 0 | 0 | 0.0% | -17.0 |
| 2026-01-19 | PHI vs. IND | W | 0.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -2.0 |
| 2026-01-14 | PHI vs. CLE | L | 6.5 | 6 | 0 | 0 | 1 | 0 | 0 | 3 | 4 | 75.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -3.0 |
| 2026-01-12 | PHI @ TOR | W | 1.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -2.0 |
| 2026-01-07 | PHI vs. WAS | W | 6.0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 1 | 2 | 50.0% | 0.0 |
| 2025-12-30 | PHI @ MEM | W | 3.6 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -4.0 |
| 2025-12-28 | PHI @ OKC | L | 19.8 | 12 | 5 | 1 | 0 | 1 | 1 | 4 | 9 | 44.4% | 4 | 7 | 57.1% | 0 | 0 | 0.0% | -5.0 |
| 2025-12-26 | PHI @ CHI | L | 4.3 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 4.0 |
| 2025-12-23 | PHI vs. BKN | L | 20.4 | 4 | 2 | 0 | 1 | 0 | 1 | 1 | 5 | 20.0% | 0 | 3 | 0.0% | 2 | 2 | 100.0% | -9.0 |
| 2025-12-20 | PHI vs. DAL | W | 13.5 | 0 | 0 | 2 | 1 | 0 | 1 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -4.0 |
| 2025-12-19 | PHI @ NYK | W | 13.7 | 8 | 1 | 0 | 2 | 0 | 0 | 2 | 4 | 50.0% | 2 | 4 | 50.0% | 2 | 2 | 100.0% | 5.0 |
| 2025-12-14 | PHI @ ATL | L | 8.8 | 0 | 2 | 1 | 1 | 1 | 0 | 0 | 5 | 0.0% | 0 | 3 | 0.0% | 0 | 0 | 0.0% | -4.0 |
| 2025-12-12 | PHI vs. IND | W | 18.6 | 0 | 2 | 3 | 0 | 0 | 0 | 0 | 5 | 0.0% | 0 | 4 | 0.0% | 0 | 0 | 0.0% | -6.0 |
| 2025-12-05 | PHI @ MIL | W | 0.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -2.0 |
| 2025-12-04 | PHI vs. GSW | W | 21.8 | 8 | 3 | 1 | 1 | 1 | 1 | 3 | 6 | 50.0% | 2 | 4 | 50.0% | 0 | 0 | 0.0% | -3.0 |
| 2025-12-02 | PHI vs. WAS | W | 33.0 | 9 | 1 | 3 | 1 | 0 | 1 | 3 | 9 | 33.3% | 3 | 7 | 42.9% | 0 | 0 | 0.0% | 14.0 |
| 2025-11-30 | PHI vs. ATL | L | 10.0 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 2 | 0.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -9.0 |
| 2025-11-28 | PHI @ BKN | W | 16.2 | 4 | 0 | 1 | 2 | 0 | 1 | 1 | 7 | 14.3% | 1 | 4 | 25.0% | 1 | 2 | 50.0% | -9.0 |
| 2025-11-25 | PHI vs. ORL | L | 22.1 | 13 | 1 | 1 | 2 | 0 | 4 | 5 | 7 | 71.4% | 1 | 2 | 50.0% | 2 | 2 | 100.0% | -16.0 |
| 2025-11-23 | PHI vs. MIA | L | 32.5 | 7 | 4 | 3 | 2 | 2 | 3 | 3 | 8 | 37.5% | 1 | 3 | 33.3% | 0 | 0 | 0.0% | -21.0 |
| 2025-11-20 | PHI @ MIL | W | 31.4 | 7 | 4 | 3 | 2 | 0 | 1 | 3 | 10 | 30.0% | 1 | 7 | 14.3% | 0 | 0 | 0.0% | 2.0 |
| 2025-11-19 | PHI vs. TOR | L | 22.6 | 8 | 2 | 2 | 1 | 0 | 2 | 2 | 6 | 33.3% | 0 | 2 | 0.0% | 4 | 4 | 100.0% | 1.0 |
| 2025-11-17 | PHI vs. LAC | W | 18.0 | 0 | 5 | 4 | 0 | 0 | 0 | 0 | 6 | 0.0% | 0 | 4 | 0.0% | 0 | 0 | 0.0% | 1.0 |
| 2025-11-14 | PHI @ DET | L | 17.4 | 13 | 1 | 1 | 0 | 0 | 1 | 4 | 7 | 57.1% | 3 | 6 | 50.0% | 2 | 2 | 100.0% | -6.0 |
| 2025-11-11 | PHI vs. BOS | W | 26.7 | 22 | 3 | 3 | 1 | 0 | 1 | 8 | 9 | 88.9% | 5 | 6 | 83.3% | 1 | 1 | 100.0% | 12.0 |
| 2025-11-08 | PHI vs. TOR | W | 7.2 | 3 | 2 | 1 | 0 | 1 | 1 | 1 | 2 | 50.0% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | -13.0 |
| 2025-11-05 | PHI @ CLE | L | 16.4 | 8 | 3 | 1 | 0 | 0 | 0 | 3 | 6 | 50.0% | 2 | 4 | 50.0% | 0 | 0 | 0.0% | -13.0 |
| 2025-11-02 | PHI @ BKN | W | 10.2 | 2 | 0 | 1 | 1 | 1 | 0 | 1 | 5 | 20.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | 11.0 |
| 2025-10-31 | PHI vs. BOS | L | 12.4 | 2 | 4 | 1 | 0 | 0 | 0 | 1 | 5 | 20.0% | 0 | 3 | 0.0% | 0 | 0 | 0.0% | -3.0 |
| 2025-10-28 | PHI @ WAS | W | 14.2 | 3 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 33.3% | 1 | 3 | 33.3% | 0 | 0 | 0.0% | -22.0 |
| 2025-10-27 | PHI vs. ORL | W | 19.1 | 5 | 1 | 1 | 0 | 0 | 0 | 2 | 5 | 40.0% | 1 | 3 | 33.3% | 0 | 0 | 0.0% | 3.0 |
| 2025-10-25 | PHI vs. CHA | W | 12.5 | 9 | 1 | 0 | 0 | 0 | 2 | 3 | 5 | 60.0% | 3 | 5 | 60.0% | 0 | 0 | 0.0% | -5.0 |
| 2025-10-22 | PHI @ BOS | W | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0.0 |